SMOC-2 Antibodies

Santa Cruz Biotechnology offers a broad range of SMOC-2 monoclonal antibodies for investigating SMOC-2 in various biological processes. SMOC-2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SMOC-2, or Spliceosome-Associated Protein 2, plays essential roles in cell adhesion, migration, and tissue remodeling. SMOC-2 expression patterns are closely associated with developmental processes and have been linked to various pathological conditions. Research has shown SMOC-2's significance as a potential biomarker in cancer and other diseases. Investigating SMOC-2 functions can reveal new therapeutic approaches and diagnostic strategies. Understanding SMOC-2's molecular mechanisms can advance knowledge in developmental biology and disease progression. Exploring SMOC-2's role in different cellular pathways may uncover novel treatment possibilities. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SMOC-2's role in human health and disease.